{{Rsnum
|rsid=651821
|Gene=APOA5
|Chromosome=11
|position=116791863
|Orientation=plus
|GMAF=0.1589
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=APOA5
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 10.6 | 88.5
| HCB | 5.8 | 40.1 | 54.0
| JPT | 12.4 | 49.6 | 38.1
| YRI | 4.1 | 32.7 | 63.3
| ASW | 1.8 | 31.6 | 66.7
| CHB | 5.8 | 40.1 | 54.0
| CHD | 5.5 | 44.0 | 50.5
| GIH | 4.0 | 25.7 | 70.3
| LWK | 0.9 | 24.5 | 74.5
| MEX | 3.4 | 29.3 | 67.2
| MKK | 1.3 | 27.6 | 71.2
| TSI | 2.0 | 17.6 | 80.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=19732897
|Title=Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese
}}

{{PMID Auto
|PMID=20395964
|Title=Different effects of apolipoprotein A5 SNPs and haplotypes on triglyceride concentration in three ethnic origins
}}

{{PMID Auto GWAS
|PMID=22171074
|Trait=None
|Title=A genome-wide association and gene-environment interaction study for serum triglycerides levels in a healthy Chinese male population.
|RiskAllele=
|Pval=9E-26
|OR=None
|ORtxt=None
}}

{{PMID Auto
|PMID=21889769
|Title=Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia
}}

{{PMID Auto
|PMID=21375366
|Title=Impact of apolipoprotein A5 (APOA5) polymorphisms on serum triglyceride levels in schizophrenic patients under long-term atypical antipsychotic treatment
}}

{{PMID Auto GWAS
|PMID=22286219
|Trait=None
|Title=Genome-wide association study identifies multiple loci influencing human serum metabolite levels.
|RiskAllele=
|Pval=8E-20
|OR=0.2700
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=17357073
|Title=Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol.
|OA=1
}}

{{PMID Auto
|PMID=17357083
|Title=Medical sequencing at the extremes of human body mass.
|OA=1
}}

{{PMID Auto
|PMID=18078817
|Title=Multiple genetic determinants of plasma lipid levels in Caribbean Hispanics.
|OA=1
}}

{{PMID Auto
|PMID=18196181
|Title=Correction of population stratification in large multi-ethnic association studies.
|OA=1
}}

{{PMID Auto
|PMID=18441017
|Title=An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients.
|OA=1
}}

{{PMID Auto
|PMID=19041386
|Title=Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.
|OA=1
}}

{{PMID Auto
|PMID=19299407
|Title=Replication of genetic associations with plasma lipoprotein traits in a multiethnic sample.
|OA=1
}}

{{PMID Auto
|PMID=19913121
|Title=Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip.
|OA=1
}}

{{PMID Auto
|PMID=20452521
|Title=Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.
|OA=1
}}

{{PMID Auto
|PMID=20570915
|Title=Genetic determinants of major blood lipids in Pakistanis compared with Europeans.
}}

{{PMID Auto GWAS
  |PMID=24386095
  |Trait=Lipid traits
  |Title=A genome wide association study identifies common variants associated with lipid levels in the Chinese population.
  |RiskAllele=C
  |Pval=2E-59
  |OR=.17
  |ORtxt=[0.14-0.20] mmol/L increase
  }}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}